Envinomycin(EVM)による肺結核の初回治療

書誌事項

タイトル別名
  • Original treatment of pulmonaly tuberculosis by enviomycin (EVM).

抄録

Thirty six cases of pulmonary tuberculosis without the previous treatment were treated with EVM for the period of 6 to 12 months in combination with RFP and INH.<BR>The results indicate that the smear negative conversion rate was 100% after 4 month treatment, and negative conversion rate by culture was 100% after 5 month treatment.<BR>Moderate or marked improvements of chest findings after 6 month was 65.7% for basic lesions and 48.9% for the cavities according to the Gakken' s criteria.<BR>As for side-effects, occurrence of hearing loss and impairement of renal function were not observed, though patients more than 50 years occupied approximately 70% of all treated patients.

収録刊行物

  • 結核

    結核 62 (9), 459-467, 1987

    一般社団法人 日本結核病学会

詳細情報 詳細情報について

  • CRID
    1390282679976155776
  • NII論文ID
    130001409122
  • DOI
    10.11400/kekkaku1923.62.459
  • ISSN
    18842410
    00229776
  • PubMed
    2828742
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • PubMed
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ